2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American …

Writing Committee Members, M Gulati, PD Levy… - Journal of the American …, 2021 - jacc.org
Aim This clinical practice guideline for the evaluation and diagnosis of chest pain provides
recommendations and algorithms for clinicians to assess and diagnose chest pain in adult …

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary …

J Knuuti, W Wijns, A Saraste, D Capodanno… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the ESC Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association …

Writing Committee Members, SS Virani… - Journal of the American …, 2023 - jacc.org
Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

[HTML][HTML] A placebo-controlled trial of percutaneous coronary intervention for stable angina

CA Rajkumar, MJ Foley, F Ahmed-Jushuf… - … England Journal of …, 2023 - Mass Medical Soc
Background Percutaneous coronary intervention (PCI) is frequently performed to reduce the
symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in …

2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …

Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

B Xu, S Tu, L Song, Z Jin, B Yu, G Fu, Y Zhou, J Wang… - The Lancet, 2021 - thelancet.com
Background Compared with visual angiographic assessment, pressure wire-based
physiological measurement more accurately identifies flow-limiting lesions in patients with …

Initial invasive or conservative strategy for stable coronary disease

DJ Maron, JS Hochman, HR Reynolds… - … England Journal of …, 2020 - Mass Medical Soc
Background Among patients with stable coronary disease and moderate or severe ischemia,
whether clinical outcomes are better in those who receive an invasive intervention plus …

Multivessel PCI guided by FFR or angiography for myocardial infarction

E Puymirat, G Cayla, T Simon, PG Steg… - … England Journal of …, 2021 - Mass Medical Soc
Background In patients with ST-elevation myocardial infarction (STEMI) who have
multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions …

2018 ESC/EACTS Guidelines on myocardial revascularization

FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management—the plaque hypothesis: a narrative …

PH Stone, P Libby, WE Boden - JAMA cardiology, 2023 - jamanetwork.com
Importance Recent clinical and imaging studies underscore that major adverse cardiac
events (MACE) outcomes are associated not solely with severe coronary obstructions …